Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID-19 pandemic.

Cavid BabaPinar YigitSeda DastanPelin HancerOzge SagiciSerkan OzakbasZuhal Abasiyanik

Published in: Neurology and clinical neuroscience (2021)

Vaccines might soon solve the pandemic's issue, which is not the case with multiple sclerosis progression, so we should think twice before discontinuing the treatment.

Keyphrases

multiple sclerosis
sars cov
coronavirus disease
white matter
combination therapy
smoking cessation